Free Trial

Can B Q2 2023 Earnings Report

Can B EPS Results

Actual EPS
-$0.37
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Can B Revenue Results

Actual Revenue
$0.42 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Can B Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Can B Earnings Headlines

WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.
See More Can B Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Can B? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Can B and other key companies, straight to your email.

About Can B

Can B (NASDAQ:CANB) engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.

View Can B Profile

More Earnings Resources from MarketBeat